IntraPace receives CE Mark for new gastric stimulation/food sensing lead

Nov 7 2011

IntraPace, Inc. announced today that it has received CE Mark for the LGL102, a new gastric stimulation/food sensing lead designed to work with the innovative abiliti® system, an implantable weight loss management system. The new lead further simplifies the implantation of the system, significantly reducing procedure time. In a recent clinical study of the new lead, procedures were consistently completed in under an hour, and operating time was reduced by 22 minutes, or 30%.

"With the new lead, the implantation procedure is further streamlined resulting in a significant reduction in implantation time. Consequently, the patient spends less time in the operating room," noted Prof. Thomas Horbach, Chief of Surgery, Stadtkrankenhaus Schwabach, the principal investigator in the LGL102 clinical study in Germany. "Reduced time in the operating room means less risk for the patient and lower overall hospital costs."

The LGL102 lead simplifies the attachment of the food sensor and stimulation electrodes to the stomach. Once attached, the sensor is able to detect food and drink, triggering the abiliti stimulator device that creates a feeling of fullness in the patient. These eating events, along with episodes of physical activity, are automatically recorded and available for downloading to a personal computer using the connect.abiliti Wand. At the user's discretion, this data may also be shared on my.abiliti.com, a lifestyle management portal and support network used by abiliti peers, friends and family, and healthcare professionals.